Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Taiho Oncology, Inc.

Clinical trials sponsored by Taiho Oncology, Inc., explained in plain language.

Now part of Otsuka Holdings Co., Ltd. 4578 TOKYO

A subsidiary of Otsuka Holdings focused on oncology treatments.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 7 Not yet finished but already full! 8 Completed 1 Terminated 6

Could a gentler dose of an oral chemo drug help MDS patients avoid transfusions?

Disease control Completed

This study tested an oral drug called ASTX727 in people with lower-risk myelodysplastic syndromes (MDS), a bone marrow disorder. The goal was to see if a lower dose given over a longer schedule could improve blood cell counts and reduce the need for transfusions. The trial enroll…

Phase: PHASE1, PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC